Presentation is loading. Please wait.

Presentation is loading. Please wait.

Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer  Vamsidhar Velcheti, MD,

Published bySuryadi Sugiarto Modified over 5 years ago

Similar presentations

Presentation on theme: "Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer  Vamsidhar Velcheti, MD,"— Presentation transcript:

1 Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer  Vamsidhar Velcheti, MD, Eve Gilstrap, RN, Jeffrey Bradley, MD, Ramaswamy Govindan, MD  Journal of Thoracic Oncology  Volume 2, Issue 9, Pages (September 2007) DOI: /JTO.0b013e31811f3a91 Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 The dose to the isocenter within the target volume was 7350 cGy. Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 A computed tomographic scan of the chest revealed an ill-defined low-attenuation lesion within the left trapezius muscle lying medial to the left scapula at the level of the fifth and sixth ribs without invasion of the underlying ribs or the adjacent scapula grossly. Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 A computed tomographic-guided biopsy of the soft tissue mass revealed only benign-appearing epithelial cells with scattered elongated nucleoli, probably representing fibroblasts. There were no features diagnostic for malignancy. A follow-up evaluation 4 months later showed spontaneous resolution of the mass. Journal of Thoracic Oncology 2007 2, DOI: ( /JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer  Vamsidhar Velcheti, MD,"

Similar presentations

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus
Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 
Pulmonary Benign Metastasizing Leiomyoma Following Hysterectomy: A Clinicopathologic Correlation  Adidam Venkata Chalapathi Rao, MD, Joyce Wilson, MBcHB,

Pulmonary Benign Metastasizing Leiomyoma Following Hysterectomy: A Clinicopathologic Correlation  Adidam Venkata Chalapathi Rao, MD, Joyce Wilson, MBcHB,
PUBLISH ONLY Journal of Thoracic Oncology

PUBLISH ONLY Journal of Thoracic Oncology
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Subroto Paul, MD, Michael Kurtz, BS, Steven J. Mentzer, MD 

Subroto Paul, MD, Michael Kurtz, BS, Steven J. Mentzer, MD 
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma  Filippo Gustavo Dall’Olio, MD, Celeste.

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma  Filippo Gustavo Dall’Olio, MD, Celeste.
Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors  Lorinda Simms, MSc, P Stat, Helen Barraclough, MSc, Ramaswamy.

Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors  Lorinda Simms, MSc, P Stat, Helen Barraclough, MSc, Ramaswamy.
Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,

Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,
MET-Mutated NSCLC with Major Response to Crizotinib

MET-Mutated NSCLC with Major Response to Crizotinib
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer

Hedgehog Signaling Pathway and Lung Cancer
Circulating tumor DNA: Solid data from liquid biopsies

Circulating tumor DNA: Solid data from liquid biopsies
Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD 

Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD 
Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer  Daniel Morgensztern, MD, Saiama.

Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer  Daniel Morgensztern, MD, Saiama.
Estrogen Receptor (ER) and Epidermal Growth Factor Receptor (EGFR) as Targets for Dual Lung Cancer Therapy: Not Just a Case?  Monica Giovannini, MD, Carmen.

Estrogen Receptor (ER) and Epidermal Growth Factor Receptor (EGFR) as Targets for Dual Lung Cancer Therapy: Not Just a Case?  Monica Giovannini, MD, Carmen.

Similar presentations

Ads by Google